Caffeic acid phenethyl ester (CAPE) exhibits significant potential as an antidiabetic and liver-protective agent in streptozotocin-induced diabetic rats

Pharmacological Research

Volumn 60, Issue 4, 2009, Pages 270-276

  Celik, Sefa ^a   Erdogan, Suat ^b   Tuzcu, Mehmet ^c  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

^b MUSTAFA KEMAL UNIVERSITY   (Turkey)

^c Adana Veteriner Kontrol Ara tirma Enstitüsü   (Turkey)

Author keywords

Caffeic acid phenethyl ester; Diabetes; Glucose metabolism; Liver

Indexed keywords

ALANINE AMINOTRANSFERASE; CAFFEIC ACID PHENETHYL ESTER; CARRIER PROTEIN; CHOLESTEROL; GLUCOKINASE; GLUCOSE; GLYCOGEN; INSULIN; MESSENGER RNA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PYRUVATE KINASE; STREPTOZOCIN; TRIACYLGLYCEROL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONNECTIVE TISSUE; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DOWN REGULATION; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG SCREENING; GENE EXPRESSION REGULATION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOGEN LIVER LEVEL; GLYCOLYSIS; HISTOPATHOLOGY; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; LIVER CELL; LIVER FUNCTION; LIVER LEVEL; LIVER NECROSIS; LIVER PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

ANIMALS; CAFFEIC ACIDS; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE; HYPOGLYCEMIC AGENTS; LIVER; MALE; PHENYLETHYL ALCOHOL; PROTECTIVE AGENTS; RATS; RATS, WISTAR; STREPTOZOCIN;

EID: 69249203820     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2009.03.017     Document Type: Article

References (42)

1. Wong A., Merritt S., Butt A.N., Williams A., and Swaminathan R. Effect of hypoxia on circulating levels of retina-specific messenger RNA in type 2 diabetes mellitus. Ann N Y Acad Sci 1137 (2008) 243-252
2. Flyvbjerg A. Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease. Diabetologia 43 (2000) 1205-1223
3. Aragno M., Parola S., Brignardello E., Mauro A., Tamagno E., Manti R., et al. Dehydroepiandrosterone prevents oxidative injury induced by transient ischemia/reperfusion in the brain of diabetic rats. Diabetes 49 (2000) 1924-1931
4. Celik S., and Erdogan S. Caffeic acid phenethyl ester (CAPE) protects brain against oxidative stress and inflammation induced by diabetes in rats. Mol Cell Biochem 312 (2008) 39-46
5. Adisakwattana S., Roengsamran S., Hsu W.H., and Yibchok-anun S. Mechanisms of antihyperglycemic effect of p-methoxycinnamic acid in normal and streptozotocin-induced diabetic rats. Life Sci 78 (2005) 406-412
6. De Sereday M.S., Gonzalez C., Giorgini D., De Loredo L., Braguinsky J., Cobeñas C., et al. Prevalence of diabetes, obesity, hypertension and hyperlipidemia in the central area of Argentina. Diabetes Metab 30 (2004) 335-339
7. Singh B.M., Palma M.A., and Nattrass M. Multiple aspects of insulin resistance. Comparison of glucose and intermediary metabolite response to incremental insulin infusion in IDDM subjects of short and long duration. Diabetes 36 (1987) 740-748
8. Ferre T., Riu E., Bosch F., and Valera A. Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver. FASEB J 10 (1996) 1213-1218
9. Le Marchand-Brustel Y., and Freychet P. Effect of fasting and streptozotocin diabetes on insulin binding and action in the isolated mouse soleus muscle. J Clin Invest 64 (1979) 1505-1515
10. Sud'ina G.F., Mirzoeva O.K., Pushkareva M.A., Korshunova G.A., Sumbatyan N.V., and Varfolomeev S.D. Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Lett 329 (1993) 21-24
11. Michaluart P., Masferrer J.L., Carothers A.M., Subbaramaiah K., Zweifel B.S., Koboldt C., et al. Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation. Cancer Res 59 (1999) 2347-2352
12. Celik S., Gorur S., Aslantas O., Erdogan S., Ocak S., and Hakverdi S. Caffeic acid phenethyl ester suppresses oxidative stress in Escherichia coli-induced pyelonephritis in rats. Mol Cell Biochem 297 (2007) 131-138
13. Chen Y.J., Shiao M.S., and Wang S.Y. The antioxidant caffeic acid phenethyl ester induces apoptosis associated with selective scavenging of hydrogen peroxide in human leukemic HL-60 cells. Anticancer Drugs 12 (2001) 143-149
14. Park E.H., and Kahng J.H. Suppressive effects of propolis in rat adjuvant arthritis. Arch Pharm Res 22 (1999) 554-558
15. Jung U.J., Lee M.K., Park Y.B., Jeon S.M., and Choi M.S. Antihyperglycemic and antioxidant properties of caffeic acid in db/db mice. J Pharmacol Exp Ther 318 (2006) 476-483
16. Park S.H., and Min T.S. Caffeic acid phenethyl ester ameliorates changes in IGFs secretion and gene expression in streptozotocin-induced diabetic rats. Life Sci 78 (2006) 1741-1747
17. Kopp U.C., Cicha M.Z., and Yorek M.A. Impaired responsiveness of renal sensory nerves in streptozotocin-treated rats and obese Zucker diabetic fatty rats: role of angiotensin. Am J Physiol Regul Integr Comp Physiol 294 (2008) 858-866
18. Bensley C.M. Comparison of methods for demonstrating glycogen microscopically. Stain Technol 14 (1939) 47
19. Roden M., and Bernroider E. Hepatic glucose metabolism in humans-its role in health and disease. Best Pract Res Clin Endocrinol Metab 17 (2003) 365-383
20. Raju J., Gupta D., Rao A.R., Yadava P.K., and Baquer N.Z. Trigonellafoenum graecum (fenugreek) seed powder improves glucose homeostasis in alloxan diabetic rat tissues by reversing the altered glycolytic, gluconeogenic and lipogenic enzymes. Mol Cell Biochem 224 August (2001) 45-51
21. Postic C., Shiota M., Niswender K.D., Jetton T.L., Chen Y., Moates J.M., et al. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J Biol Chem 274 (1999) 305-315
22. Iynedjian P.B., Gjinovci A., and Renold A.E. Stimulation by insulin of glucokinase gene transcription in liver of diabetic rats. J Biol Chem 263 (1988) 740-744
23. Friedman J.E., Sun Y., Ishizuka T., Farrell C.J., McCormack S.E., Herron L.M., et al. Phosphoenolpyruvate carboxykinase (GTP) gene transcription and hyperglycemia are regulated by glucocorticoids in genetically obese db/db transgenic mice. J Biol Chem 272 (1997) 31475-31481
24. Hsu F.L., Chen Y.C., and Cheng J.T. Caffeic acid as active principle from the fruit of Xanthium strumarium to lower plasma glucose in diabetic rats. Planta Med 66 (2000) 228-230
25. Cheng J.T., Liu I.M., Tzeng T.F., Chen W.C., Hayakawa S., and Yamamoto T. Release of beta-endorphin by caffeic acid to lower plasma glucose in streptozotocin-induced diabetic rats. Horm Metab Res 35 (2003) 251-258
26. Sud'ina G.F., Mirzoeva O.K., Pushkareva M.A., Korshunova G.A., SumbatyanNV, and Varfolomeev S.D. Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Lett 329 (1993) 21-24
27. Son S., and Lewis B.A. Free radical scavenging and antioxidative activity of caffeic acid amide and ester analogues: structure-activity relationship. J Agric Food Chem 50 (2002) 468-472
28. Granner D., and Pilkis S. The genes of hepatic glucose metabolism. J Biol Chem 265 (1990) 10173-10176
29. Jump D.B. Fatty acid regulation of gene transcription. Crit Rev Clin Lab Sci 41 (2004) 41-78
30. Jump D.B., Botolin D., Wang Y., Xu J., Christian B., and Demeure O. Fatty acid regulation of hepatic gene transcription. J Nutr 135 (2005) 2503-2506
31. Towle H.C. Glucose as a regulator of eukaryotic gene transcription. Trends Endocrinol Metab 16 (2005) 489-494
32. Xu J., Christian B., and Jump D.B. Regulation of rat hepatic L-pyruvate kinase promoter composition and activity by glucose, n-3 polyunsaturated fatty acids, and peroxisome proliferator-activated receptor-alpha agonist. J Biol Chem 281 (2006) 18351-18362
33. Oka Y., Asano T., Shibasaki Y., Lin J.L., Tsukuda K., Akanuma Y., et al. Increased liver glucose-transporter protein and mRNA in streptozocin-induced diabetic rats. Diabetes 39 (1990) 441-446
34. Sindhu R.K., Koo J.R., Roberts C.K., and Vaziri N.D. Dysregulation of hepatic SOD, CAT and GPx in diabetes: response to insulin and antioxidant therapy. Clin Exp Hypertension 26 (2004) 43-53
35. Hishikawa K., Nakaki T., and Fujita T. Oral flavonoid supplementation attenuates atherosclerosis development in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 25 (2005) 442-446
36. Al-Shamaony L., Al-Khazraji S.M., and Twaij H.A. Hypoglycaemic effect of Artemisia herba alba. II. Effect of a valuable extract on some blood parameters in diabetic animals. J Ethnopharmacol 43 (1994) 167-171
37. Kudchodkar B.J., Lee M.J., Lee S.M., DiMarco N.M., and Lacko A.G. Effect of dietary protein on cholesterol homeostasis in diabetic rats. J Lipid Res 29 (1988) 1272-1287
38. Braun J.E., and Severson D.L. Lipoprotein lipase release from cardiac myocytes is increased by decavanadate but not insulin. Am J Physiol 262 5 Pt 1 (1992) E663-E670
39. Lopes-Virella M.F., Wohltmann H.J., Mayfield R.K., Loadholt C.B., and Colwell J.A. Effect of metabolic control on lipid, lipoprotein, and apolipoprotein levels in 55 insulin-dependent diabetic patients. A longitudinal study. Diabetes 32 (1983) 20-25
40. Vetrichelvan T., Jegadeesan M., and Devi B.A. Anti-diabetic activity of alcoholic extract of Celosia argentea Linn. seeds in rats. Biol Pharm Bull 25 (2002) 526-528
41. Bollen M., Keppens S., and Stalmans W. Specific features of glycogen metabolism in the liver. Biochem J 336 Pt 1 (1998) 19-31
42. Vasanthakumari V., and Shyamaladevi C.S. Biochemical evaluation of Tarakeshwara Rasa-antidiabetic drug in rats. Indian Drugs 35 (1998) 140-143